In the Original Investigation titled “Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial,”1 published May 28, 2020, there was an error in the affiliation of co-author Andreas Fellgiebel. The correct affiliation is Center for Mental Health in Old Age, Landeskrankenhaus, Department of Psychiatry and Psychotherapy, University Medical Center, Mainz, Germany. This article has been corrected.1
Reference
- 1.Maier F, Spottke A, Bach JP, et al. Bupropion for the treatment of apathy in Alzheimer disease: a randomized clinical trial. JAMA Netw Open. 2020;3(5):e206027. doi: 10.1001/jamanetworkopen.2020.6027 [DOI] [PMC free article] [PubMed] [Google Scholar]